CompuMed Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Mar '12 Mar 31, 2012	Sep '11 Sep 30, 2011	Sep '10 Sep 30, 2010	Sep '09 Sep 30, 2009	Sep '08 Sep 30, 2008	Sep '07 Sep 30, 2007
Revenue	1.69	1.68	1.76	2.05	2.15	2.22
Revenue Growth (YoY)	0.47%	-4.60%	-13.96%	-4.88%	-2.84%	4.83%
Cost of Revenue	0.84	0.8	0.74	0.75	0.91	0.72
Gross Profit	0.85	0.88	1.02	1.29	1.24	1.5
Selling, General & Admin	0.9	1.08	1.24	1.3	2.06	2.08
Research & Development	-	-	0.01	0.04	0.42	0.41
Operating Expenses	0.98	1.18	1.37	1.5	2.59	2.57
Operating Income	-0.13	-0.3	-0.35	-0.2	-1.35	-1.08
Interest Expense	-0.02	-0.03	-0.03	-0.05	-0.05	-0.03
Interest & Investment Income	-	-	-	0	0.03	0.08
Other Non Operating Income (Expenses)	0.11	0.1	-	-	-	-
EBT Excluding Unusual Items	-0.04	-0.22	-0.38	-0.25	-1.37	-1.03
Gain (Loss) on Sale of Investments	-	-	-	-	-0.07	-0.36
Gain (Loss) on Sale of Assets	-	-	-	-0	-	-
Asset Writedown	-	-	-	-	-0.04	-
Pretax Income	-0.04	-0.22	-0.38	-0.25	-1.48	-1.38
Net Income	-0.04	-0.22	-0.38	-0.25	-1.48	-1.38
Preferred Dividends & Other Adjustments	0.11	0.07	0.09	-	-	-
Net Income to Common	-0.15	-0.3	-0.47	-0.25	-1.48	-1.38
Shares Outstanding (Basic)	1	1	1	1	1	1
Shares Outstanding (Diluted)	1	1	1	1	1	1
Shares Change (YoY)	1.66%	2.27%	3.54%	2.00%	3.31%	3.70%
EPS (Basic)	-0.13	-0.27	-0.44	-0.24	-1.46	-1.40
EPS (Diluted)	-0.13	-0.27	-0.44	-0.24	-1.46	-1.40
Free Cash Flow	-0.01	-0.04	-0.16	-0.08	-1.03	-0.63
Free Cash Flow Per Share	-0.01	-0.03	-0.15	-0.07	-1.01	-0.64
Gross Margin	50.24%	52.29%	58.12%	63.18%	57.73%	67.60%
Operating Margin	-7.73%	-17.96%	-19.75%	-9.86%	-62.56%	-48.56%
Profit Margin	-8.62%	-17.55%	-26.50%	-12.35%	-68.65%	-62.27%
Free Cash Flow Margin	-0.83%	-2.08%	-9.31%	-3.81%	-47.89%	-28.57%
EBITDA	-0.05	-0.2	-0.22	-0.05	-1.24	-0.99
EBITDA Margin	-2.66%	-11.66%	-12.66%	-2.54%	-57.50%	-44.72%
D&A For EBITDA	0.09	0.11	0.13	0.15	0.11	0.09
EBIT	-0.13	-0.3	-0.35	-0.2	-1.35	-1.08
EBIT Margin	-7.73%	-17.96%	-19.75%	-9.86%	-62.56%	-48.56%
Revenue as Reported	1.69	1.68	1.76	2.05	2.15	2.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.